Brain Morphological Changes Accompanied by Effective Biologic Treatments for Psoriasis and Their Associations With the Improvement of Well-being, Itch, and Pain
Latest Information Update: 23 Aug 2024
At a glance
- Drugs Secukinumab (Primary)
- Indications Psoriasis; Psoriatic arthritis
- Focus Pharmacodynamics
- 21 Aug 2024 Status changed from recruiting to active, no longer recruiting.
- 18 Mar 2024 Planned End Date changed from 1 Jul 2024 to 31 Aug 2024.
- 18 Mar 2024 Planned primary completion date changed from 31 Mar 2024 to 31 Aug 2024.